HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,765-1,776 of 1,811
Drug study icon
CompletedNCT03785223

Methylphenidate Hydrochloride Controlled Release Capsules for ADHD

Official study title

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

This study has finished and is no longer accepting participants.

In Hamilton
Anxiety, ADHDMedication studyAges 18–65
Countries
Canada
Sponsor
McMaster University
Drug study icon
CompletedNCT02287038

Atomoxetine in Veterans With Comorbid ADHD/PTSD

Official study title

Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study

This study has finished and is no longer accepting participants.

In Charleston
PTSD, ADHDMedication studyAges 20–60
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Other study type icon
TerminatedNCT01506232

Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolarity, or Autism Spectrum Disorders: A Preliminary Study

Official study title

Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study

This study ended early.

In Cambridge
Bipolarity, ADHDObservational studyAges 6–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00936299

Bupropion for ADHD in Adolescents With Addiction

Official study title

Bupropion for ADHD in Adolescents With Substance Use Disorder

This study has finished and is no longer accepting participants.

In Denver
Addiction, ADHDMedication studyAges 13–19
Countries
United States
Sponsor
University of Colorado, Denver
Behavioral study icon
CompletedNCT04336072

Reminder Focused Positive Psychiatry in Adolescents With ADHD and PTSD

Official study title

Trial of Reminder Focused Positive Psychiatry in Comorbid Attention Deficit Hyperactive Disorder With Posttraumatic Stress Disorder

This study has finished and is no longer accepting participants.

In Los Angeles
PTSD, ADHDBehavioural studyAges 9–18
Countries
United States
Sponsor
University of California, Los Angeles
Drug study icon
CompletedNCT06973577

P3b Short-term Study of CTN in people with ADHD and Comorbid Anxiety

Official study title

A Phase 3b, Randomized, Double-blind, 8-week, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Centanafadine Once Daily Extended-release Capsules for the Treatment of Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
Anxiety, ADHDMedication studyAges 18–65
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.